Skip to main content

Advertisement

SpringerLink
Log in

Clinical and Biochemical Features of Pheochromocytoma Characteristic of Von Hippel–Lindau Syndrome

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Approximately 30% of patients with apparent sporadic pheochromocytoma (Pheo) may later prove to have an inherited predisposition syndrome, most commonly Von Hippel–Lindau (VHL) disease. Our aim was to compare the clinical and biochemical features of Pheo in VHL to those in sporadic disease to identify differences that may be used to guide management and surveillance of Pheo in VHL patients.

Methods

Data of all patients who had adrenalectomy for histologic Pheo from 2000 to 2018 (QIIRB1749) were retrospectively reviewed. VHL patients were diagnosed by standard clinical criteria and/or genetic testing. Patients were classified as having sporadic Pheo (sPheo) if they had no family/personal history consistent with an associated genetic disorder and/or had negative testing for VHL, MAX, MEN1, NF1, RET and SDHAF2/B/C/D/A mutations.

Results

Of 175 patients, 38 (22%) had VHL and 137 (78%) had sPheo including 27 (20%) with negative genetic testing. Compared to sPheo, VHL Pheo patients were younger (mean 25.9 vs. 51.2 years, p < 0.001), less symptomatic (55% vs. 72%, p = 0.074), less hypertensive (46% vs. 64%, p = 0.043) and were more likely to have normal plasma metanephrines (85% vs. 25%, p < 0.001). VHL-related Pheos were smaller (median 2.8 cm vs. 4.4 cm, p < 0.001) but more often multifocal (>1 adrenal Pheo) (16% vs. 0%, p < 0.001). Recurrence >6 months from initial resection was common in VHL (40% vs. 0%, p < 0.001), median time to recurrence 15 years, (range 1–38 years).

Conclusions

Compared to those with sporadic Pheo, patients with VHL are more likely to be young, asymptomatic and normotensive and to have small, multifocal, normetanephrine-secreting tumors. Because recurrence is common in VHL and arises up to 38 years later, continued surveillance is advised.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chen H, Sippel RS, O’Dorisio MS et al (2013) The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 42:557–577

    Article  Google Scholar 

  2. Lenders JW, Eisenhofer G, Mannelli M et al (2005) Phaeochromocytoma. Lancet 366:665–675

    Article  Google Scholar 

  3. Guerrero MA, Schreinemakers JMJ, Menno VR et al (2009) Clinical spectrum of pheochromocytoma. J Am Coll Surg 209:727–732

    Article  Google Scholar 

  4. Cron J, Taieb D, Pacak K (2017) New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification. Endocr Rev 38:489–515

    Article  Google Scholar 

  5. Pillai S, Gopalan V, Smith RA et al (2016) Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era. Crit Rev Oncol Hematol 100:190–208

    Article  Google Scholar 

  6. Gimenez-Roqueplo AP, Dahia PL, Robledo M (2012) An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes. Horm Metab Res 44:328–333

    Article  CAS  Google Scholar 

  7. Karasek D, Zdenek F, Pacak K (2011) Genetic testing for pheochromocytoma. Curr Hypertens Rep 12:456–464

    Article  Google Scholar 

  8. Buffet A, Aim LB, Leboulleux S et al (2019) Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma. J Clin Endocrinol Metab 104:1109–1118

    Article  Google Scholar 

  9. Neumann HPH, Bausch B, McWhinney SR et al (2002) Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 346:1459–1466

    Article  CAS  Google Scholar 

  10. Iacobone M, Schiavi F, Bottussi M et al (2011) Is genetic screening indicated in apparently sporadic pheochromocytomas and paragangliomas? Surgery 150:1194–1201

    Article  Google Scholar 

  11. Brito JP, Asi N, Bancos I et al (2015) Testing for germline mutations in sporadic pheochromocytoma/paraganlioma: a systematic review. Clin Endocrinol 82:338–345

    Article  CAS  Google Scholar 

  12. Bryant J, Farmer J, Kessler LJ et al (2003) Pheochromocytoma: the expanding genetic differential diagnosis. J Natl Cancer Inst 95:1196–1204

    Article  CAS  Google Scholar 

  13. Fishbein L, Leshchiner I, Walter V et al (2017) Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31:181–193

    Article  CAS  Google Scholar 

  14. Favier J, Amar L, Gimenez-Roqueplo AP (2015) Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol 11:101–111

    Article  CAS  Google Scholar 

  15. Muth A, Crona J, Gimm O et al (2019) Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma. J Intern Med 285:187–204

    CAS  PubMed  Google Scholar 

  16. Nielsen SM, Rhodes L, Blanco I et al (2016) Von Hippel-Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome. J Clin Oncol 34:2172–2181

    Article  CAS  Google Scholar 

  17. Nielsen SM, Rubinstein WS, Thull DL et al (2011) Genotype–Phenotype correlations of Pheochromocytoma in two large von Hippel-Lindau type 2A kindreds with different missense mutations. Am J Med Genet A 155A:168–173

    Article  Google Scholar 

  18. Baghai M, Thompson GB, Young WF et al (2002) Pheochromoytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery. Arch Surg 137:682–689

    Article  Google Scholar 

  19. Walther MM, Reiter R, Keiser HR et al (1999) Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pehochromocytoma gives insight into natural history of pheochromocytoma. J Urol 162:659–664

    Article  CAS  Google Scholar 

  20. Eisenhofer G, Walther MM, Thanh-Truc H et al (2001) Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. J Clin Endocrinol Metab 86:1999–2008

    Article  CAS  Google Scholar 

  21. Aufforth RD, Ramakant P, Sadowski SM et al (2015) Pheochromocytoma screening initiation and frequency in von Hippel-Lindau syndrome. J Clin Endocrinol Metab 100:4498–4504

    Article  CAS  Google Scholar 

  22. Eisenhofer G, Lenders JWM, Linehan WM et al (1999) Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340:1872–1879

    Article  CAS  Google Scholar 

  23. Neumann H, Berger DP, Sigmund G et al (1993) Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 329:1531–1538

    Article  CAS  Google Scholar 

  24. Richard S, Beigelman C, Duclos JM et al (1994) Pheochromocytoma as the first manifestation of von Hippel-Lindau disease. Surgery 166:1076–1081

    Google Scholar 

  25. Lenders JW, Duh QY, Eisenhofer G et al (2014) Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99:1915–1942

    Article  CAS  Google Scholar 

Download references

Funding

No external funding for this manuscript.

Author information

Authors and Affiliations

  1. Department of General Surgery, University of Pittsburgh Medical Center, Kaufman Building, Suite 101, 3471 Fifth Ave, Pittsburgh, PA, 15213, USA

    Shimena R. Li & Kristina J. Nicholson

  2. Division of Endocrine Surgery, University of Pittsburgh Medical Center, Kaufman Building, Suite 101, 3471 Fifth Ave, Pittsburgh, PA, 15213, USA

    Kelly L. Mccoy, Sally E. Carty & Linwah Yip

Authors
  1. Shimena R. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kristina J. Nicholson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kelly L. Mccoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sally E. Carty
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Linwah Yip
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Linwah Yip.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, S.R., Nicholson, K.J., Mccoy, K.L. et al. Clinical and Biochemical Features of Pheochromocytoma Characteristic of Von Hippel–Lindau Syndrome. World J Surg 44, 570–577 (2020). https://doi.org/10.1007/s00268-019-05299-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-019-05299-y

Search

Navigation